Showing 861 - 880 results of 27,374 for search '(( 50 ((mm decrease) OR (nn decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 1.02s Refine Results
  1. 861
  2. 862
  3. 863

    S7 Fig - by Magdalena R. Raykova (16455790)

    Published 2023
    “…This is consistent with the reported potential of the EDTA-Fe(III) redox couple by Allcorn et al. when considered in the context of the Ag/AgCl QRE used here and the scan rate of 50 mV/s [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0287824#pone.0287824.ref061" target="_blank">61</a>]. …”
  4. 864
  5. 865
  6. 866
  7. 867
  8. 868

    The <i>P[syt<sup>P-L</sup>]</i> mutation decreases the Ca<sup>2+</sup> affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

    Published 2017
    “…<p>(A) Mean EJP amplitudes from <i>+/-;P[syt<sup>WT</sup>]/+</i> (filled black circles) and <i>+/-;P[syt<sup>P-L</sup>]/+</i> (filled red circles) larvae at Ca<sup>2+</sup> levels ranging from 0.05 mM5.0 mM. …”
  9. 869

    Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer by Ana Alfaro (280118)

    Published 2016
    “…Interestingly, when analyzing only the HPV16-positive CC, D2 increases (OR = 2.5, 95% CI = 1.2–5, p < 0.05) and D3 decreases (OR = 0.45, 95% CI 0.2–0.9, p < 0.05) the risk to develop CC before 50 years old in relation with A1/2 variant. …”
  10. 870
  11. 871
  12. 872
  13. 873

    HDAC inhibitors block the proliferative rate of radial glia cells. by Yi Tao (178829)

    Published 2015
    “…<p>(A). Representative co-staining images showing the BrdU- and BLBP-positive cells in control (A1–A3), TSA-treated (50 nM, A4–A6) and VPA-treated (1 mM, A7–A9) tecta. …”
  14. 874
  15. 875
  16. 876
  17. 877
  18. 878
  19. 879
  20. 880

    Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled T... by Chunfeng Qu (114656)

    Published 2014
    “…The estimated efficacy of catch-up vaccination on HBsAg seroprevalence in early adulthood was 21% (95% CI 10%–30%), substantially weaker than that of the neonatal vaccination (72%, 95% CI 68%–75%). Receiving a booster at age 10–14 years decreased HBsAg seroprevalence if participants were born to HBsAg-positive mothers (hazard ratio [HR] = 0.68, 95% CI 0.47–0.97). …”